Senior Consultant on Law, Health Policy and Ethics
Beth E. Roxland is a seasoned Attorney & Bioethicist with multifaceted experience across industry, law, government & academia. Beth is a Strategic Advisor on Law, Policy & Bioethics at Roxland Consultants, Ltd., where she counsels life-science, health care & biomedical entities, clinical researchers, advocacy groups and professional associations on legal, ethical, operational & PR issues. Ms. Roxland serves in a range of capacities tailored to clients’ needs, formulating practical approaches to complex issues, delivering solutions that bridge multiple areas of expertise.
Ms. Roxland is also the Principal of a law firm specializing in litigation, public policy, crafting legislation and governmental oversight frameworks, compliance & regulatory matters.
She is also a frequent public speaker & author, and serves on several academic & research oversight boards.
Ms. Roxland’s prior Executive roles include serving as:
-> Johnson & Johnson’s Bioethics and Strategy Leader, in the Global Chief Medical Officer’s Office
-> Executive Director of The New York State Task Force on Life & the Law (NYS’s Bioethics Commission)
-> Special Advisor to the Commissioner of Health on Stem Cell Research Ethics
-> Southern District of NY (SDNY) Judicial Law Clerk
-> Senior Litigation Associate at Simpson Thacher & Bartlett
-> Adjunct Professor of Law at NYU School of Law
Ms. Roxland graduated from Columbia University with a degree in Biology, and from the University of Pennsylvania with joint degrees in Law and Bioethics (J.D. – M.Bioethics) magna cum laude.
POLICY: Expanded Access & Compassionate Use ~ CRISPR & genomics ~ stem cell & regenerative medicine policy and procedures ~ health tech & apps ~ Right to Try ~ charging and reimbursement for research interventions ~ Real World Evidence ~ Public Health ~ return of research results ~ biobanking ~ trial design & recruitment ~ subject compensation ~ IRB education & operations ~ research with special populations (eg, adults with Alzheimer’s or other capacity-impacting conditions) ~ data gathering, monitoring, & transparency ~ patient engagement ~ informed consent ~ genetically-modified (GMO) tech & labeling ~ medical tourism ~ Opioid Crisis ~ journal retractions
LAW: Litigation ~ regulation ~ contracts ~ life sciences/ food & drug law ~ drafting legislation and regulation for global and domestic governmental entites ~ privacy ~ insurance ~ healthcare ~ trademark & copyright ~ mass torts ~ white collar crime & internal investigations ~ arbitration & mediation ~ compliance ~ family law ~ conflicts of interest